Treatment outcomes of HIV-positive patients on first-line antiretroviral therapy in private versus public HIV clinics in Johannesburg, South Africa

被引:16
|
作者
Moyo, Faith [1 ]
Chasela, Charles [2 ,3 ]
Brennan, Alana T. [1 ,4 ]
Ebrahim, Osman [5 ]
Sanne, Ian M. [1 ,6 ]
Long, Lawrence [1 ]
Evans, Denise [1 ]
机构
[1] Univ Witwatersrand, Hlth Econ & Epidemiol Res Off, Dept Internal Med, Sch Clin Med,Fac Hlth Sci, Unit 2,39 Empire Rd, ZA-2193 Johannesburg, South Africa
[2] Univ Witwatersrand, Sch Publ Hlth, Epidemiol & Biostat Dept, Fac Hlth Sci, Johannesburg, South Africa
[3] Human Sci Res Council, Epidemiol & Strateg Informat ESI HIV AIDS STIs &, Pretoria, South Africa
[4] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA
[5] Brenthurst Clin, Parktown, South Africa
[6] Right To Care, Helen Joseph Hosp, Johannesburg, South Africa
来源
CLINICAL EPIDEMIOLOGY | 2016年 / 8卷
关键词
health systems; attrition; HIV programs; viral suppression; SUB-SAHARAN AFRICA; EARLY MORTALITY; FOLLOW-UP; CARE; PROGRAM; ADHERENCE; SECTOR; COHORT; INDIA; RISK;
D O I
10.2147/CLEP.S93014
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Despite the widely documented success of antiretroviral therapy(ART), stakeholders continue to face the challenges of poor HIV treatment outcomes. While many studies have investigated patient-level causes of poor treatment outcomes, data on the effect of health systems on ART outcomes are scarce. Objective: We compare treatment outcomes among patients receiving HIV care and treatment at a public and private HIV clinic in Johannesburg, South Africa. Patients and methods: This was a retrospective cohort analysis of ART naive adults (>= 18.0 years), initiating ART at a public or private clinic in Johannesburg between July 01, 2007 and December 31, 2012. Cox proportional-hazards regression was used to identify baseline predictors of mortality and loss to follow-up (>3 months late for the last scheduled visit). Generalized estimating equations were used to determine predictors of failure to suppress viral load (>= 400 copies/mL) while the Wilcoxon rank-sum test was used to compare the median absolute change in CD4 count from baseline to 12 months post-ART initiation. Results: 12,865 patients initiated ART at the public clinic compared to 610 at the private clinic. The patients were similar in terms of sex and age at initiation. Compared to public clinic patients, private clinic patients initiated ART at higher median CD4 counts(159 vs 113 cells/mm(3)) and World Health Organization stage I/II(76.1% vs 58.5%). Adjusted hazard models showed that compared to public clinic patients, private clinic patients were less likely to die(adjusted hazard ratio [aHR] 0.50; 95% confidence interval [CI] 0.35-0.70) but were at increased risk of loss to follow-up(aHR 1.80; 95% CI 1.59-2.03). By 12 months post-ART initiation, private clinic patients were less likely to have a detectable viral load(adjusted relative risk 0.65; 95% CI 0.49-0.88) and recorded higher median CD4 change from baseline(184 cells/mm(3) interquartile range 101-300 vs 158 cells/mm3 interquartile range 91-244), when compared to public clinic patients. Conclusion: We identified differences in treatment outcomes between the two HIV clinics. Findings suggest that the type of clinic at which ART patients initiate and receive treatment can have an impact on treatment outcomes. Further research is necessary to provide more conclusive results.
引用
收藏
页码:37 / 46
页数:10
相关论文
共 50 条
  • [21] A Novel Markov Model Projecting Costs and Outcomes of Providing Antiretroviral Therapy to Public Patients in Private Practices versus Public Clinics in South Africa
    Leisegang, Rory
    Maartens, Gary
    Hislop, Michael
    Sargent, John
    Darkoh, Ernest
    Cleary, Susan
    PLOS ONE, 2013, 8 (02):
  • [22] A STUDY OF MODIFICATION TO FIRST-LINE ANTIRETROVIRAL THERAPY IN TREATMENT NAIVE, HIV POSITIVE PATIENTS IN A TERTIARY CARE HOSPITAL
    Shenoy, Smita
    Malalur, Chaithanya
    Shrivastava, Dhairya
    Varma, Muralidhar
    Saravu, Kavitha
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2017, 13 (04): : E35 - E35
  • [23] Antiretroviral therapy uptake and predictors of virological failure in patients with HIV receiving first-line and second-line regimens in Johannesburg, South Africa: a retrospective cohort data analysis
    Gumede, Siphamandla Bonga
    Venter, Francois
    de Wit, John
    Wensing, Annemarie
    Lalla-Edward, Samanta Tresha
    BMJ OPEN, 2022, 12 (04):
  • [24] HIV-disclosure in the context of vertical transmission: HIV-positive mothers in Johannesburg, South Africa
    Varga, C. A.
    Sherman, G. G.
    Jones, S. A.
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2006, 18 (08): : 952 - 960
  • [25] Implementation and outcomes of dolutegravir-based first-line antiretroviral therapy for people with HIV in South Africa: a retrospective cohort study
    Dorward, Jienchi
    Sookrajh, Yukteshwar
    Khubone, Thokozani
    van der Molen, Johan
    Govender, Riona
    Phakathi, Sifiso
    Lewis, Lara
    Bottomley, Christian
    Maraj, Munthra
    Lessells, Richard J.
    Naidoo, Kogieleum
    Butler, Christopher C.
    Van Heerden, Rose
    Garrett, Nigel
    LANCET HIV, 2023, 10 (05): : E284 - E294
  • [26] Incident tuberculosis in HIV-positive children, adolescents and adults on antiretroviral therapy in South Africa
    Brennan, A. T.
    Bonawitz, R.
    Schnippel, K.
    Berhanu, R.
    Maskew, M.
    Long, L.
    Bassett, J.
    Sanne, I.
    Fox, M. P.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (08) : 1040 - 1045
  • [27] Highly active antiretroviral therapy and cervical dysplasia in HIV-positive women in South Africa
    Firnhaber, Cynthia
    Westreich, Daniel
    Schulze, Doreen
    Williams, Sophie
    Siminya, Maureen
    Michelow, Pam
    Levin, Simon
    Faesen, Mark
    Smith, Jennifer S.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15
  • [28] HIV Transmission Risk Behavior Among HIV-Positive Patients Receiving Antiretroviral Therapy in KwaZulu-Natal, South Africa
    Paul A. Shuper
    Susan M. Kiene
    Gethwana Mahlase
    Susan MacDonald
    Sarah Christie
    Deborah H. Cornman
    William A. Fisher
    Ross Greener
    Umesh G. Lalloo
    Sandy Pillay
    Francois van Loggerenberg
    Jeffrey D. Fisher
    AIDS and Behavior, 2014, 18 : 1532 - 1540
  • [29] Changes in Risk Behavior Among HIV-Positive Patients During Their First Year of Antiretroviral Therapy in Cape Town South Africa
    Thomas P. Eisele
    Catherine Mathews
    Mickey Chopra
    Mark N. Lurie
    Lisanne Brown
    Sarah Dewing
    Carl Kendall
    AIDS and Behavior, 2009, 13 : 1097 - 1105
  • [30] Changes in Risk Behavior Among HIV-Positive Patients During Their First Year of Antiretroviral Therapy in Cape Town South Africa
    Eisele, Thomas P.
    Mathews, Catherine
    Chopra, Mickey
    Lurie, Mark N.
    Brown, Lisanne
    Dewing, Sarah
    Kendall, Carl
    AIDS AND BEHAVIOR, 2009, 13 (06) : 1097 - 1105